HTA's support for the Government’s 10 Year Health Plan for England
The HTA welcomes the 10-year plan and the focus it provides on promoting innovation, development, and improvements across the health system.
We will do all we can to support implementation of the plan.
The plan's emphasis on digital transformation, preventative healthcare, and community-based services presents significant opportunities.
As the independent regulator responsible for maintaining public confidence in the safe and trusted handling of human tissue, we recognise that our work will be increasingly important as tissue-based treatments and diagnostic applications play a growing role in the healthcare transformation described in the plan.
We will support the 10 Year Plan through progressing key activities, including those contained with our HTA Strategy 2024-27, such as:
- Evolve our regulatory model to ensure regulation supports rather than hinders innovation while maintaining safety standards for tissue use through proportionate and bespoke approaches.
- Enhancing digital and data capabilities to improve information accessibility, streamline processes, and harness emerging technologies that support more efficient regulation.
- Upholding foundational principles of consent, dignity, quality, and openness as tissue and genomic information becomes increasingly central to early detection and preventative healthcare.
- Strengthening partnerships across the healthcare ecosystem to create a seamless regulatory environment that complements broader health initiatives through effective collaboration with other regulators, providers, and research institutions.
- Being open to working in different ways and within a landscape of different regulatory structures, as highlighted by the Dash Review, whilst focusing on enhancing how we deliver the functions covered by our statutory and regulatory responsibilities.
Central to our approach is reducing the regulatory burden while maintaining safety standards. Our Innovation in Inspections project is seeking to reduce administrative requirements and provide compliant establishments with lighter touch interactions. We're implementing changes in four key areas: using data to focus on areas of greatest risk, reviewing Codes of Practice, accelerating digital transformation, and reducing administrative costs. This will create a proportionate framework that supports growth in UK life sciences while maintaining public trust and confidence.